Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy: population based study

V Pierrat, N Haouari, A Liska, D Thomas, D Subtil, P Truffert, Groupe d'Etudes en Epidémiologie Périnatale, V Pierrat, N Haouari, A Liska, D Thomas, D Subtil, P Truffert, Groupe d'Etudes en Epidémiologie Périnatale

Abstract

Objectives: To ascertain the prevalence of newborn encephalopathy in term live births, and also the underlying diagnoses, timing, and outcome at 2 years of surviving infants.

Design: Population based observational study.

Setting: North Pas-de-Calais area of France, January to December 2000.

Patients: All 90 neonates with moderate or severe newborn encephalopathy.

Results: The prevalence of moderate or severe newborn encephalopathy was 1.64 per 1000 term live births (95% confidence interval (CI) 1.30 to 1.98). The prevalence of birth asphyxia was 0.86 per 1000 term live births (95% CI 0.61 to 1.10). The main cause of newborn encephalopathy was birth asphyxia, diagnosed in 47 (52%) infants. It was associated with another diagnosis in 11/47 cases (23%). The timing was intrapartum in 56% of cases, antepartum in 13%, ante-intrapartum in 10%, and postpartum in 2%. In 19% of cases, no underlying cause was identified during the neonatal course. Twenty four infants died in the neonatal period, giving a fatality rate of 27% (95% CI 17% to 36%). Three infants died after the neonatal period. At 2 years of age, 38 infants had a poor outcome, defined by death or severe disability, a prevalence of 0.69 per 1000 term live births (95% CI 0.47 to 0.91). In infants with isolated birth asphyxia, this prevalence was 0.36 per 1000 term live births (95% CI 0.20 to 0.52).

Conclusions: The causes of newborn encephalopathy were heterogeneous but the main one was birth asphyxia. The prevalence was low, but the outcome was poor, emphasising the need for prevention programmes and new therapeutic approaches.

References

    1. Lancet. 2003 Mar 1;361(9359):736-42
    1. J Obstet Gynaecol. 2001 Mar;21(2):114-20
    1. Acta Paediatr. 2001 Mar;90(3):271-7
    1. Arch Fr Pediatr. 1977 Aug-Sep;34(7):687-8
    1. BMJ. 1999 Oct 16;319(7216):1054-9
    1. BMJ. 1998 Dec 5;317(7172):1549-53
    1. Ment Retard Dev Disabil Res Rev. 2002;8(3):146-50
    1. Acta Paediatr Scand. 1975 Mar;64(2):187-92
    1. BMJ. 1998 Dec 5;317(7172):1554-8
    1. Am J Dis Child. 1991 Nov;145(11):1325-31
    1. J Pediatr. 1988 Apr;112(4):515-9
    1. Dev Med Child Neurol. 2000 Dec;42(12):803-8
    1. Arch Neurol. 1976 Oct;33(10):696-705
    1. Pediatrics. 2002 Jan;109(1):26-33
    1. Neuropediatrics. 1994 Dec;25(6):301-7
    1. Arch Dis Child Fetal Neonatal Ed. 2002 Nov;87(3):F176-80
    1. Rev Fr Gynecol Obstet. 1971 Jun-Jul;66(6):391-6
    1. Acta Obstet Gynecol Scand. 2002 Oct;81(10):909-17
    1. J Gynecol Obstet Biol Reprod (Paris). 2001 Oct;30(6):552-64
    1. J Epidemiol Community Health. 2000 Sep;54(9):660-6

Source: PubMed

3
Iratkozz fel